RO7247669
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RO7247669, covering 2026-02-04 to 2026-02-04. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Multiple Doses of RO7247669 in Participants With Previously Untreated Unresectable or Metastatic Melanoma [Phase 2]